{"transactions":[{"id":4633264,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-10-01T16:00:08.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":false,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."}],"balance_after":1843,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":921},"source":{"system":"sec-edgar","filing":"0001193125-26-409858","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526409858/ownership.xml","form_type":"4"}},{"id":4633263,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-01T16:00:08.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":true,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the issuer's Common Stock."}],"balance_after":2450,"source":{"system":"sec-edgar","filing":"0001193125-26-409858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526409858/ownership.xml","form_type":"4"}},{"id":721865,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-01T20:30:10.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."}],"balance_after":2764,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":922},"source":{"system":"sec-edgar","filing":"0001193125-26-292648","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526292648/ownership.xml","form_type":"4"}},{"id":721864,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T20:30:10.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the issuer's Common Stock."}],"balance_after":1529,"source":{"system":"sec-edgar","filing":"0001193125-26-292648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526292648/ownership.xml","form_type":"4"}},{"id":775706,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:12:10.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":3686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest monthly over 12 months from the grant date in substantially equal monthly increments, provided that the options vest in full on the Issuer's 2027 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":3686,"derivative":{"exercise_price":5.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":3686},"source":{"system":"sec-edgar","filing":"0001193125-26-228930","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526228930/ownership.xml","form_type":"4"}},{"id":775705,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-18T20:12:10.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":3686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."}],"balance_after":3686,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3686},"source":{"system":"sec-edgar","filing":"0001193125-26-228930","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526228930/ownership.xml","form_type":"4"}},{"id":972927,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-11T22:50:41.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer."}],"balance_after":161326,"source":{"system":"sec-edgar","filing":"0001193125-25-316315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525316315/ownership.xml","form_type":"4"}},{"id":998111,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-17T21:38:18.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":false,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016."}],"balance_after":0,"derivative":{"exercise_price":1.46,"expiration_date":"2025-12-15","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0001193125-25-284702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525284702/ownership.xml","form_type":"4"}},{"id":998110,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-17T21:38:18.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":true,"shares":5860,"price":1.46,"value":8555.6,"ownership":{"direct":true},"balance_after":121326,"source":{"system":"sec-edgar","filing":"0001193125-25-284702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525284702/ownership.xml","form_type":"4"}},{"id":1065798,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-15T20:29:10.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":397794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":397794,"derivative":{"exercise_price":0.5744,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":397794},"source":{"system":"sec-edgar","filing":"0000950170-25-109412","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017025109412/ownership.xml","form_type":"4"}},{"id":1104166,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T18:39:22.000Z","date":"2025-06-20","kind":"purchase","planned":false,"acquired":true,"shares":48225,"price":2.044,"value":98571.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average purchase price. The purchase prices ranged from $2.0345 to $2.045. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":115466,"source":{"system":"sec-edgar","filing":"0000950170-25-088895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017025088895/ownership.xml","form_type":"4"}},{"id":1256799,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-20T22:30:11.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":40122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":40122,"derivative":{"exercise_price":1.18,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":40122},"source":{"system":"sec-edgar","filing":"0000950170-25-024344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017025024344/ownership.xml","form_type":"4"}},{"id":1331159,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T22:53:56.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":8000,"price":3.3211,"value":26568.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy tax liability upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price is a weighted average sales price. The sale prices ranged from $3.29 to $3.36. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":67241,"source":{"system":"sec-edgar","filing":"0000950170-24-136780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024136780/ownership.xml","form_type":"4"}},{"id":1331158,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T22:53:56.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer."}],"balance_after":75241,"source":{"system":"sec-edgar","filing":"0000950170-24-136780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024136780/ownership.xml","form_type":"4"}},{"id":1332901,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":17.35,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":28475},"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1332900,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":10.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":35400},"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1332899,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":135000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.87,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1332898,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":3.52,"underlying":"Common Stock","underlying_shares":35400},"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1332897,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":35400},"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1332896,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":1.84,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":19624},"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1332895,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4469,"ownership":{"direct":false,"nature":"By Charitable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC (\"DPV\") (the \"Merger Agreement\") in exchange for (i) $4.25 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share.  Each restricted stock unit (\"RSU\") was cancelled and will receive the Cash Amount plus one CVR per RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1332894,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-13T21:32:39.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":753093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC (\"DPV\") (the \"Merger Agreement\") in exchange for (i) $4.25 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share.  Each restricted stock unit (\"RSU\") was cancelled and will receive the Cash Amount plus one CVR per RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001126234-24-000122","document":"wk-form4_1734143552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000122/wk-form4_1734143552.xml","form_type":"4"}},{"id":1405800,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T11:00:04.000Z","date":"2024-09-13","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":1.499,"value":5996.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.47 to $1.50 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15188,"source":{"system":"sec-edgar","filing":"0000950170-24-107008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024107008/ownership.xml","form_type":"4"}},{"id":1407011,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-16T11:00:03.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":6285,"price":1.3543,"value":8511.7755,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.27 or $1.40 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11188,"source":{"system":"sec-edgar","filing":"0000950170-24-106605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024106605/ownership.xml","form_type":"4"}},{"id":1409083,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-12T20:30:07.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":3650,"derivative":{"exercise_price":1.26,"expiration_date":"2034-09-11","underlying":"Common Stock","underlying_shares":3650},"source":{"system":"sec-edgar","filing":"0000950170-24-105959","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024105959/ownership.xml","form_type":"4"}},{"id":1521088,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2024-05-10T11:30:09.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":9804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The expiration date for 4,902 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,902 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Half of the warrants are Series A warrants and the other half are Series B warrants."}],"balance_after":9804,"derivative":{"exercise_price":1.79,"exercise_date":"2024-05-08","underlying":"Common Stock Warrants","underlying_shares":9804},"source":{"system":"sec-edgar","filing":"0000950170-24-057453","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024057453/ownership.xml","form_type":"4"}},{"id":1521087,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T11:30:09.000Z","date":"2024-05-08","kind":"purchase","planned":false,"acquired":true,"shares":4902,"price":2.04,"value":10000.08,"ownership":{"direct":true},"balance_after":4903,"source":{"system":"sec-edgar","filing":"0000950170-24-057453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024057453/ownership.xml","form_type":"4"}},{"id":1550729,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T17:10:01.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":35400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on May 1, 2024, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant."}],"balance_after":35400,"derivative":{"exercise_price":2.84,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":35400},"source":{"system":"sec-edgar","filing":"0001126234-24-000035","document":"wk-form4_1712178581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000035/wk-form4_1712178581.xml","form_type":"4"}},{"id":1550728,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T17:10:01.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1522,"price":2.84,"value":4322.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 6,250 previously reported RSUs granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 583 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,250 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 3,375 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":753093,"source":{"system":"sec-edgar","filing":"0001126234-24-000035","document":"wk-form4_1712178581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000035/wk-form4_1712178581.xml","form_type":"4"}},{"id":1550727,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T17:10:01.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":2.84,"value":12780.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on April 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 583 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,250 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 3,375 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":754615,"source":{"system":"sec-edgar","filing":"0001126234-24-000035","document":"wk-form4_1712178581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000035/wk-form4_1712178581.xml","form_type":"4"}},{"id":1620399,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:24:18.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":2250,"derivative":{"exercise_price":2.03,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0000950170-24-020412","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017024020412/ownership.xml","form_type":"4"}},{"id":1659437,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-05T17:54:14.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":690,"price":3.01,"value":2076.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 2,832 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,250 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person on April 1, 2024, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 583 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 2,250 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 3,375 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":750115,"source":{"system":"sec-edgar","filing":"0001126234-24-000015","document":"wk-form4_1707173641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000015/wk-form4_1707173641.xml","form_type":"4"}},{"id":1709648,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T22:33:32.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 14, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":35241,"source":{"system":"sec-edgar","filing":"0001209191-23-058844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123058844/doc4.xml","form_type":"4"}},{"id":1714799,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-12T23:09:48.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":false,"shares":10841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 12, 2014."}],"balance_after":0,"derivative":{"exercise_price":0.82,"expiration_date":"2023-12-12","underlying":"Common Stock","underlying_shares":10841},"source":{"system":"sec-edgar","filing":"0001209191-23-058353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123058353/doc4.xml","form_type":"4"}},{"id":1714798,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-12T23:09:48.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":true,"shares":10841,"price":0.82,"value":8889.62,"ownership":{"direct":true},"balance_after":12741,"source":{"system":"sec-edgar","filing":"0001209191-23-058353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123058353/doc4.xml","form_type":"4"}},{"id":1929367,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-04T17:21:19.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1522,"price":3.31,"value":5037.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 6,250 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,165 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,250 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person on April 1, 2024, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 3,375 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 4,500 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":750805,"source":{"system":"sec-edgar","filing":"0001126234-23-000049","document":"wf-form4_168064326092391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000049/wf-form4_168064326092391.xml","form_type":"4"}},{"id":1969971,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Preferred Stock","published_at":"2023-03-07T00:40:17.000Z","date":"2023-03-03","kind":"purchase","acquired":true,"shares":1,"price":1000,"value":1000.0,"ownership":{"direct":true},"balance_after":1,"source":{"system":"sec-edgar","filing":"0001209191-23-016526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919123016526/doc4.xml","form_type":"4"}},{"id":2008801,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T21:32:09.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":20182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":20182,"derivative":{"exercise_price":0.39,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":20182},"source":{"system":"sec-edgar","filing":"0001209191-23-010652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919123010652/doc4.xml","form_type":"4"}},{"id":2033587,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T17:02:31.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":35400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the Reporting Person of a stock option under the Plan.  50% of the option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 1, 2023, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.  The option expires ten years after the Date of Grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The remaining 50% of the stock options vest and become exercisable in 3 substantially equal tranches on the first of the month following an increase of closing stock price, as defined as the closing stock price on Nasdaq Stock Market by at least 50%, 100% and 150%, respectively, above the closing stock on December 31, 2022, when measured over 30 consecutive calendar days, provided such increase occurs within two years of the Date of Grant, otherwise such options shall be cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Unless otherwise disclosed, the option expires ten years after the date of grant."}],"balance_after":35400,"derivative":{"exercise_price":3.52,"underlying":"Common Stock","underlying_shares":35400},"source":{"system":"sec-edgar","filing":"0001126234-23-000013","document":"wf-form4_167546173552737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000013/wf-form4_167546173552737.xml","form_type":"4"}},{"id":2033586,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T17:02:31.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":416,"price":3.52,"value":1464.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 1,707 previously reported RSUs granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,165 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,500 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 3,375 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":752327,"source":{"system":"sec-edgar","filing":"0001126234-23-000013","document":"wf-form4_167546173552737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000013/wf-form4_167546173552737.xml","form_type":"4"}},{"id":2033585,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T17:02:31.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":4500,"price":3.52,"value":15840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan, as amended, (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,165 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,500 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 3,375 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":752743,"source":{"system":"sec-edgar","filing":"0001126234-23-000013","document":"wf-form4_167546173552737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000013/wf-form4_167546173552737.xml","form_type":"4"}},{"id":2085370,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-15T21:09:31.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable on December 13, 2023."}],"balance_after":40000,"derivative":{"exercise_price":1.51,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-061415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919122061415/doc4.xml","form_type":"4"}},{"id":2092400,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-08T22:08:26.000Z","date":"2022-12-07","kind":"exercise","acquired":false,"shares":1172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 14, 2013."}],"balance_after":0,"derivative":{"exercise_price":0.65,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":1172},"source":{"system":"sec-edgar","filing":"0001209191-22-060376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919122060376/doc4.xml","form_type":"4"}},{"id":2092399,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-08T22:08:26.000Z","date":"2022-12-07","kind":"exercise","acquired":true,"shares":1172,"price":0.65,"value":761.8,"ownership":{"direct":true},"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001209191-22-060376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919122060376/doc4.xml","form_type":"4"}},{"id":2152135,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-23T17:05:25.000Z","date":"2022-09-23","kind":"purchase","acquired":true,"shares":208,"price":8.8,"value":1830.4,"ownership":{"direct":false,"nature":"By Charitable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $8.76 to $8.80, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."}],"balance_after":4469,"source":{"system":"sec-edgar","filing":"0001126234-22-000105","document":"wf-form4_166396710487697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000105/wf-form4_166396710487697.xml","form_type":"4"}},{"id":2152134,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-23T17:05:25.000Z","date":"2022-09-21","kind":"purchase","acquired":true,"shares":2214,"price":8.84,"value":19571.76,"ownership":{"direct":false,"nature":"By Charitable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $8.50 to $8.90, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."}],"balance_after":4261,"source":{"system":"sec-edgar","filing":"0001126234-22-000105","document":"wf-form4_166396710487697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000105/wf-form4_166396710487697.xml","form_type":"4"}},{"id":2153604,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-21T18:45:36.000Z","date":"2022-09-20","kind":"purchase","acquired":true,"shares":1506,"price":8.75,"value":13177.5,"ownership":{"direct":false,"nature":"By Charitable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $8.74 to $8.75, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2047,"source":{"system":"sec-edgar","filing":"0001126234-22-000103","document":"wf-form4_166380032181273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000103/wf-form4_166380032181273.xml","form_type":"4"}},{"id":2153603,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-21T18:45:36.000Z","date":"2022-09-19","kind":"purchase","acquired":true,"shares":541,"price":8.65,"value":4679.65,"ownership":{"direct":false,"nature":"By Charitable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $8.51 to $8.75, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."}],"balance_after":541,"source":{"system":"sec-edgar","filing":"0001126234-22-000103","document":"wf-form4_166380032181273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000103/wf-form4_166380032181273.xml","form_type":"4"}},{"id":2305273,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-05T17:28:03.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":1466,"price":9.23,"value":13531.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 6,250 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,747 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,500 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 4,500 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":748243,"source":{"system":"sec-edgar","filing":"0001126234-22-000032","document":"wf-form4_164919405905428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000032/wf-form4_164919405905428.xml","form_type":"4"}},{"id":2414622,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T16:34:37.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":35400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 1, 2022, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant."}],"balance_after":35400,"derivative":{"exercise_price":10.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":35400},"source":{"system":"sec-edgar","filing":"0001126234-22-000007","document":"wf-form4_164392405843089.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000007/wf-form4_164392405843089.xml","form_type":"4"}},{"id":2414621,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-03T16:34:37.000Z","date":"2022-02-01","kind":"tax_withholding","acquired":false,"shares":173,"price":10.02,"value":1733.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 582 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,747 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 18,750 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on April 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":749709,"source":{"system":"sec-edgar","filing":"0001126234-22-000007","document":"wf-form4_164392405843089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000007/wf-form4_164392405843089.xml","form_type":"4"}},{"id":2414620,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-03T16:34:37.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":4500,"price":10.02,"value":45090.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan, as amended, (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,747 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 18,750 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on April 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":749882,"source":{"system":"sec-edgar","filing":"0001126234-22-000007","document":"wf-form4_164392405843089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000007/wf-form4_164392405843089.xml","form_type":"4"}},{"id":2473846,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T23:28:03.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable on December 14, 2022."}],"balance_after":40000,"derivative":{"exercise_price":1.11,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-069582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121069582/doc4.xml","form_type":"4"}},{"id":2473845,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T23:28:03.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 16, 2012."}],"balance_after":0,"derivative":{"exercise_price":0.55,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":728},"source":{"system":"sec-edgar","filing":"0001209191-21-069582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121069582/doc4.xml","form_type":"4"}},{"id":2473844,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-14T23:28:03.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":728,"price":0.55,"value":400.4,"ownership":{"direct":true},"balance_after":728,"source":{"system":"sec-edgar","filing":"0001209191-21-069582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121069582/doc4.xml","form_type":"4"}},{"id":2672602,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:43:08.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":6336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":6336,"derivative":{"exercise_price":2.88,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":6336},"source":{"system":"sec-edgar","filing":"0001209191-21-040096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919121040096/doc4.xml","form_type":"4"}},{"id":2672601,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:43:08.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal monthly installments over 36 months."}],"balance_after":40000,"derivative":{"exercise_price":2.88,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-040096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919121040096/doc4.xml","form_type":"4"}},{"id":2758518,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-05T17:45:33.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":1522,"price":12.25,"value":18644.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 6,250 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,329 RSUs previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 18,750 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on April 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":745382,"source":{"system":"sec-edgar","filing":"0001126234-21-000042","document":"wf-form4_161765904078536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000042/wf-form4_161765904078536.xml","form_type":"4"}},{"id":2882455,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T18:51:13.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":28475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 1, 2021, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant."}],"balance_after":28475,"derivative":{"exercise_price":17.35,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":28475},"source":{"system":"sec-edgar","filing":"0001126234-21-000007","document":"wf-form4_161239625958826.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000007/wf-form4_161239625958826.xml","form_type":"4"}},{"id":2882454,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T18:51:13.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":2329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan, as amended, (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 25,000 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on April 1, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":746904,"source":{"system":"sec-edgar","filing":"0001126234-21-000007","document":"wf-form4_161239625958826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000007/wf-form4_161239625958826.xml","form_type":"4"}},{"id":2940498,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T17:17:10.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable on December 16, 2021."}],"balance_after":40000,"derivative":{"exercise_price":1.23,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-063975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919120063975/doc4.xml","form_type":"4"}},{"id":3097854,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T00:47:10.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over two years in equal 1/24th increments on each monthly anniversary of the issuance."}],"balance_after":40000,"derivative":{"exercise_price":2.1,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-039319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919120039319/doc4.xml","form_type":"4"}},{"id":3183935,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-03T18:21:23.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on May 1, 2020, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant."}],"balance_after":135000,"derivative":{"exercise_price":7.87,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001126234-20-000044","document":"wf-form4_158595246403664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623420000044/wf-form4_158595246403664.xml","form_type":"4"}},{"id":3183934,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-04-03T18:21:23.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan, as amended, (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on April 1, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":744575,"source":{"system":"sec-edgar","filing":"0001126234-20-000044","document":"wf-form4_158595246403664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623420000044/wf-form4_158595246403664.xml","form_type":"4"}},{"id":3331449,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-26T23:04:50.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":12000,"derivative":{"exercise_price":1.59,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-19-030074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319030074/doc4.xml","form_type":"4"}},{"id":3524139,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 16, 2012."}],"balance_after":728,"derivative":{"exercise_price":0.55,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":444},"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524138,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":2288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on November 18, 2011."}],"balance_after":0,"derivative":{"exercise_price":0.52,"expiration_date":"2021-08-30","underlying":"Common Stock","underlying_shares":2288},"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524137,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 17, 2011."}],"balance_after":0,"derivative":{"exercise_price":0.52,"expiration_date":"2020-12-17","underlying":"Common Stock","underlying_shares":586},"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524136,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":21682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"5,420 of the shares subject to the option vested and became exercisable on October 22, 2010, and the remaining shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 22, 2011."}],"balance_after":0,"derivative":{"exercise_price":0.52,"expiration_date":"2020-10-22","underlying":"Common Stock","underlying_shares":21682},"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524135,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-15","kind":"sale","acquired":false,"shares":10409,"price":11.1602,"value":116166.5218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average sale price. The sale prices ranged from $10.99 to $11.31. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524134,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":14591,"price":11.0654,"value":161455.2514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average sale price. The sale prices ranged from $10.97 to $11.16. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":10409,"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524133,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":444,"price":0.55,"value":244.2,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524132,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":2288,"price":0.52,"value":1189.76,"ownership":{"direct":true},"balance_after":24556,"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524131,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":586,"price":0.52,"value":304.72,"ownership":{"direct":true},"balance_after":22268,"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3524130,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:38:55.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":21682,"price":0.52,"value":11274.64,"ownership":{"direct":true},"balance_after":21682,"source":{"system":"sec-edgar","filing":"0000899243-19-013799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319013799/doc4.xml","form_type":"4"}},{"id":3730893,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T21:31:52.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 13, 2018, subject to the reporting person's continued service with the Issuer."}],"balance_after":12000,"derivative":{"exercise_price":7.33,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-031085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924318031085/doc4.xml","form_type":"4"}},{"id":3860223,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2018-07-27T20:33:26.000Z","date":"2018-07-25","kind":"other","acquired":true,"shares":10500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the \"Company\") to all holders of the Company's common stock and Series B Preferred Stock on June 26, 2018. The subscription rights entitled each recipient to purchase units (\"Units\"). Each Unit consists of one share of the Company's Series C Preferred stock (convertible into 1,253 of the Company's common stock) and 1,050 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $0.7986 through January 25, 2021."}],"balance_after":10500,"derivative":{"exercise_price":0.7986,"expiration_date":"2021-01-25","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-18-044208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919118044208/doc4.xml","form_type":"4"}},{"id":3860222,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-07-27T20:33:26.000Z","date":"2018-07-25","kind":"other","acquired":true,"shares":10,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the \"Company\") to all holders of the Company's common stock and Series B Preferred Stock on June 26, 2018. The subscription rights entitled each recipient to purchase units (\"Units\"). Each Unit consists of one share of the Company's Series C Preferred stock (convertible into 1,253 of the Company's common stock) and 1,050 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series C Preferred Stock has no expiration date."}],"balance_after":35,"derivative":{"exercise_price":0.7986,"exercise_date":"2018-07-25","underlying":"Common Stock","underlying_shares":12522},"source":{"system":"sec-edgar","filing":"0001209191-18-044208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919118044208/doc4.xml","form_type":"4"}},{"id":3860221,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subscription Rights (Right to Buy)","published_at":"2018-07-27T20:33:26.000Z","date":"2018-07-25","kind":"other","acquired":false,"shares":10,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the \"Company\") to all holders of the Company's common stock and Series B Preferred Stock on June 26, 2018. The subscription rights entitled each recipient to purchase units (\"Units\"). Each Unit consists of one share of the Company's Series C Preferred stock (convertible into 1,253 of the Company's common stock) and 1,050 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the \"Company\") to all holders of the Company's common stock and Series B Preferred Stock on June 26, 2018. The subscription rights entitled each recipient to purchase units (\"Units\"). Each Unit consists of one share of the Company's Series C Preferred stock (convertible into 1,253 of the Company's common stock) and 1,050 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the \"Company\") to all holders of the Company's common stock and Series B Preferred Stock on June 26, 2018. The subscription rights entitled each recipient to purchase units (\"Units\"). Each Unit consists of one share of the Company's Series C Preferred stock (convertible into 1,253 of the Company's common stock) and 1,050 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2018-06-29","expiration_date":"2018-07-20","underlying":"See Footnote"},"source":{"system":"sec-edgar","filing":"0001209191-18-044208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919118044208/doc4.xml","form_type":"4"}},{"id":4126680,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T23:47:22.000Z","date":"2017-12-17","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer."}],"balance_after":3750,"derivative":{"exercise_price":15.21,"expiration_date":"2027-12-17","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000899243-17-029233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924317029233/doc4.xml","form_type":"4"}},{"id":4149408,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2017-11-29T22:35:32.000Z","date":"2017-11-28","kind":"other","acquired":true,"shares":5400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, In. (the \"Company\") to all holders of the Company's common stock on October 27, 2017.  The subscription rights entitled each recipient to purchase units (\"Units\").  Each Unit consists of one share of the Company's Series B Preferred Stock (convertible into 3,000 shares of the Company's common stock) and 1,800 warrants, with each warrant representing the right to purchase one share of the Company's common stock.  The purchase price for each Unit was $1,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $0.3333 per share from the date the Company receives stockholder approval of an amendment to its certificate of incorporation to increase its authorized shares of common stock through May 28, 2020."}],"balance_after":5400,"derivative":{"exercise_price":0.3333,"expiration_date":"2020-05-28","underlying":"Common Stock","underlying_shares":5400},"source":{"system":"sec-edgar","filing":"0001209191-17-062898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919117062898/doc4.xml","form_type":"4"}},{"id":4149407,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2017-11-29T22:35:32.000Z","date":"2017-11-28","kind":"other","acquired":true,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, In. (the \"Company\") to all holders of the Company's common stock on October 27, 2017.  The subscription rights entitled each recipient to purchase units (\"Units\").  Each Unit consists of one share of the Company's Series B Preferred Stock (convertible into 3,000 shares of the Company's common stock) and 1,800 warrants, with each warrant representing the right to purchase one share of the Company's common stock.  The purchase price for each Unit was $1,000."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Preferred Stock has no expiration date."}],"balance_after":3,"derivative":{"exercise_price":0.3333,"exercise_date":"2017-11-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-17-062898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919117062898/doc4.xml","form_type":"4"}},{"id":4149406,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subscription Rights (Right to Buy)","published_at":"2017-11-29T22:35:32.000Z","date":"2017-11-28","kind":"other","acquired":false,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, In. (the \"Company\") to all holders of the Company's common stock on October 27, 2017.  The subscription rights entitled each recipient to purchase units (\"Units\").  Each Unit consists of one share of the Company's Series B Preferred Stock (convertible into 3,000 shares of the Company's common stock) and 1,800 warrants, with each warrant representing the right to purchase one share of the Company's common stock.  The purchase price for each Unit was $1,000."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, In. (the \"Company\") to all holders of the Company's common stock on October 27, 2017.  The subscription rights entitled each recipient to purchase units (\"Units\").  Each Unit consists of one share of the Company's Series B Preferred Stock (convertible into 3,000 shares of the Company's common stock) and 1,800 warrants, with each warrant representing the right to purchase one share of the Company's common stock.  The purchase price for each Unit was $1,000."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, In. (the \"Company\") to all holders of the Company's common stock on October 27, 2017.  The subscription rights entitled each recipient to purchase units (\"Units\").  Each Unit consists of one share of the Company's Series B Preferred Stock (convertible into 3,000 shares of the Company's common stock) and 1,800 warrants, with each warrant representing the right to purchase one share of the Company's common stock.  The purchase price for each Unit was $1,000."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2017-11-02","expiration_date":"2017-11-21","underlying":"see footnote"},"source":{"system":"sec-edgar","filing":"0001209191-17-062898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919117062898/doc4.xml","form_type":"4"}},{"id":4186034,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-16T17:06:41.000Z","date":"2017-10-13","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":0.28,"value":8400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the \"Merger\") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Under its terms the option became exercisable in installments at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant (June 8, 2017), and became immediately exercisable and vested in full as of the date ten (10) days prior to the Merger."}],"balance_after":0,"derivative":{"exercise_price":10.9,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-024249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/880771/000089924317024249/doc4.xml","form_type":"4"}},{"id":4186033,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-16T17:06:41.000Z","date":"2017-10-13","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":2.03,"value":60900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the \"Merger\") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Under its terms the option became exercisable in installments at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant (June 11, 2015), and became immediately exercisable and vested in full as of June 11, 2016."}],"balance_after":0,"derivative":{"exercise_price":9.15,"expiration_date":"2025-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-024249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/880771/000089924317024249/doc4.xml","form_type":"4"}},{"id":4186032,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-16T17:06:41.000Z","date":"2017-10-13","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":6.08,"value":182400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the \"Merger\") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Under its terms the option became exercisable in installments at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant (June 12, 2014), and became immediately exercisable and vested in full as of June 12, 2015."}],"balance_after":0,"derivative":{"exercise_price":5.1,"expiration_date":"2024-06-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-024249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/880771/000089924317024249/doc4.xml","form_type":"4"}},{"id":4186031,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-16T17:06:41.000Z","date":"2017-10-13","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":6.05,"value":181500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the \"Merger\") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Under its terms the option became exercisable in installments at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant (June 27, 2013), and became immediately exercisable and vested in full as of June 27, 2014."}],"balance_after":0,"derivative":{"exercise_price":5.13,"expiration_date":"2023-06-27","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-024249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/880771/000089924317024249/doc4.xml","form_type":"4"}},{"id":4186030,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-16T17:06:41.000Z","date":"2017-10-13","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":4.4,"value":132000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the \"Merger\") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Under its terms the option became exercisable in installments at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant (June 7, 2012), and became immediately exercisable and vested in full as of June 7, 2013."}],"balance_after":0,"derivative":{"exercise_price":6.78,"expiration_date":"2022-06-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-024249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/880771/000089924317024249/doc4.xml","form_type":"4"}},{"id":4186029,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-16T17:06:41.000Z","date":"2017-10-13","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":5.14,"value":154200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the \"Merger\") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Under its terms the option became exercisable in installments at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant (June 30, 2011), and became immediately exercisable and vested in full as of June 30, 2012."}],"balance_after":0,"derivative":{"exercise_price":6.04,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-024249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/880771/000089924317024249/doc4.xml","form_type":"4"}},{"id":4186028,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-16T17:06:41.000Z","date":"2017-10-13","kind":"disposition_to_issuer","acquired":false,"shares":24363,"price":11.18,"value":272378.34,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-024249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/880771/000089924317024249/doc4.xml","form_type":"4"}},{"id":4287760,"issuer":{"id":172474,"kind":"organization","name":"SCICLONE PHARMACEUTICALS INC","symbol":"SCLN"},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Board Member"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-06-09T16:28:29.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted under the Issuer's 2015 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option shall vest and become exercisable at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant except that, in the event of a change in control, any unexercisable or unvested portions of outstanding options shall be immediately exercisable and vested in full as of the date ten (10) days prior to the change in control, regardless of whether the option is assumed or substituted for by the acquirer."}],"balance_after":30000,"derivative":{"exercise_price":10.9,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000880771-17-000101","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/880771/000088077117000101/certent-form4.xml","form_type":"4"}},{"id":4479512,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34209,"kind":"person","name":"Hawkins Richard J","position":1,"cik":"0001307632","reported_name":"Hawkins Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-27T22:49:57.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person received a non-qualified stock option granted under the Issuer's 2014 Equity Incentive Plan.  The exercise price per share to be paid by the reporting person at the time the option is exercised is the closing sale price of the Issuer's Common Stock on the NASDAQ Stock Market as of the date of the grant.  The closing sale price on the date of the grant was $1.56."}],"balance_after":25000,"derivative":{"exercise_price":1.56,"exercise_date":"2018-01-26","expiration_date":"2027-01-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-005975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000120919117005975/doc4.xml","form_type":"4"}}]}